Ishihara Tomoaki, Hoshino Tatsuya, Namba Takushi, Tanaka Ken-ichiro, Mizushima Tohru
Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto 862-0973, Japan.
Biochem Biophys Res Commun. 2007 May 11;356(3):711-7. doi: 10.1016/j.bbrc.2007.03.034. Epub 2007 Mar 13.
NSAIDs such as celecoxib induce apoptosis in cancer cells. Although this apoptotic effect is involved in the anti-tumor activity associated with such drugs, the mechanism by which this occurs is not fully understood. We report here that various NSAIDs, including celecoxib, up-regulate PUMA, a Bcl-2 family protein with potent apoptosis-inducing activity, in human gastric carcinoma cell line, accompanying the induction of apoptosis. Experiments using siRNA and an intracellular Ca(2+) chelator revealed that Ca(2+)-dependent up-regulation of ATF4 and CHOP is involved in this up-regulation of PUMA. The siRNA for PUMA inhibited the celecoxib-induced activation and translocation of Bax, release of cytochrome c into the cytosol and induction of apoptosis, suggesting that PUMA plays an important role in celecoxib-induced mitochondrial dysfunction and the resulting apoptosis.
非甾体抗炎药(NSAIDs)如塞来昔布可诱导癌细胞凋亡。尽管这种凋亡效应与这类药物的抗肿瘤活性有关,但其发生机制尚未完全明确。我们在此报告,包括塞来昔布在内的多种NSAIDs可上调人胃癌细胞系中具有强大凋亡诱导活性的Bcl-2家族蛋白PUMA,并伴随凋亡的诱导。使用小干扰RNA(siRNA)和细胞内Ca(2+)螯合剂的实验表明,ATF4和CHOP的Ca(2+)依赖性上调参与了PUMA的这种上调。PUMA的siRNA抑制了塞来昔布诱导的Bax激活和易位、细胞色素c释放到胞质溶胶以及凋亡的诱导,这表明PUMA在塞来昔布诱导的线粒体功能障碍及由此导致的凋亡中起重要作用。